GlaxoSmithKline and Oxford University (GO) launched the PRECISE Alliance (Pre-Cancer Biology and Immunoprevention) in 2024, with the aim of conducting deep exploration of cancer precursors (precancers) to identify their molecular vulnerabilities and developing methods to intercept them. The alliance is led by Professor Sarah Blagden.

As part of this effort, we are launching a dynamic seminar series designed to bring together experts and enthusiasts from across the university and GSK. These sessions will focus on pre-cancer biology, immunology, and cutting-edge topics in cancer prevention. Held every 4–6 weeks during term time, they will offer a fantastic opportunity to exchange ideas and drive progress in this vital field.
If you’re passionate about contributing, we’d love to hear from you—get in touch and be part of this pioneering initiative!